Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Everyday Challenges in Veterinary Anesthesia Diane E. Mason, DVM, PhD Clinical Associate Professor, Anesthesiology Kansas State University Presented to the Metropolitan New Jersey Veterinary Medical Association Meeting June 18, 2014 There are occasionally the routine cases that move us through our daily schedule. More often it seems that the routine case is highlighted by some “extenuating circumstances” that present an extra challenge for anesthetic management when that is a part of the plan for the animal on that day. Add into that the common emergency presentations that walk into the clinic on a regular basis and conducting anesthesia in a busy practice will always require thoughtful planning interspersed with spur of the moment exercisesin good judgment. The title of this talk could be: “A Day in the Life of a Veterinary Anesthesiologist”.Recognizing that most of you are not veterinary anesthesiologists, it is important to see that the examples of cases that we will talk about are not dissimilar from many that you might encounter. The important take home message is that there are a number of ways to anesthetize any given case, with respect to drug choices. Often the most important thing about successful anesthesia comes down to perioperative management as much as specific anesthetic drug choices that are made. During the seminar we should try to have a dialogue so that each of you feels comfortable talking about how you might manage a given case or situation based on the resources that you have available in your individual practice situations. As a general rule, the approach to general anesthesia in most of the patients anesthetized at Kansas State University follow a fairly predictable pattern. A typical scenario would include premedication with a sedative/tranquilizer. Common choices might be: acepromazine or a benzodiazepine (diazepam or midazolam) or an alpha-2 agonist (dexmedetomidine). The advantage to incorporation of premedication into the protocol is to improve patient cooperation for catheter placement and handling. It provides for a smoother induction and sometimes recovery. It reduces the dose of other agents needed for induction and maintenance of anesthesia, just to name a few. In addition, we almost always choose to add an opioid to the premedication plan, if pain is a part of the procedure that is about to be performed. This would be true for anything from dentistry to major surgery. The choices of opioids are wide from shorter to longer acting, partial to full agonist etc. The decision of which to use is based on the circumstance of the procedure and patient needs. Anesthetic induction takes place with an intravenous induction agent after IV catheter placement. Propofol is by far the most commonly used induction agent at our clinic, but ketamine with or without a diazepam is also frequently used. On occasion, intravenous opioids are used to achieve intubation in a sick or debilitated animal or etomidate in animals with significant cardiovascular impairment. Inhalation anesthesia is still the major means by which general anesthesia is maintained for the majority of patients in small animal veterinary medicine. In recent years, the use of continuous rate infusions of intravenous adjunctive agents to allow less reliance on inhalant during the maintenance phase has become more commonplace. In every animal that we anesthetize we always take into account the particular analgesic needs of that animal for the procedure it is about to undergo. What level of pain is going to be involved? Is there anything additionally that can be done to help alleviate what the animal is going to experience? If systemic opioids were to be used, what dose and interval would be necessary to adequately meet the analgesic requirements for the patient? Can a CRI of opioids or a combination of drugs provide a better intraoperative or postoperative analgesic experience and can that be managed for this patient? Is there a local anesthetic technique that might be appropriate to incorporate for this particular procedure that could help during the intraoperative and immediate postoperative period? These are the basic questions that come into play for planning each anesthetic protocol even for the most uncomplicated patient. What about a patient that then presents with specific complicating factors? How are these weighed and how do they change the process of anesthetic planning? The safest anesthetic approach to an animal with underlying health issues that could affect their risk for anesthesia would be to have a diagnosis. As an example, if laboratory data reveals an elevation in BUN and creatinine, that signals azotemia. Azotemia itself is not a diagnosis. This sign could be from pre-renal, renal or post-renal causes. This is where some further knowledge and having a diagnosis can markedly alter your approach to the management of the case. If further work-up would point to a likely renal cause for the azotemia, then from an anesthetic standpoint you need to have an understanding about the pathophysiology of renal disease. You may need some further diagnostics to determine the progression of the primary renal disease in this patient. What are the factors that influence glomerular filtration and urine output and how are they affected by general anesthesia? Are there choices we can make in a drug protocol that will support rather than decompensate an already compromised kidney? It then becomes a matter of prioritizing problems on your patient’s problem list. If this small animal patient with azotemia requires general anesthesia for an ophthalmologic procedure, you can choose to anesthetize it, bearing in mind that maintaining normotension is of utmost importance in order to keep adequate renal perfusion. In addition, despite the fact that ophthalmic procedures might be given systemic NSAID’s for their anti-inflammatory and analgesic effects as part of the pre-operative medication, that would not be done in this instance.We have placed renal protection at the top of our problem list and NSAID’s are now contraindicated for use during general anesthesia when their effect on renal blood flow in low perfusion states, as might occur in we encounter hypotension, could be deleterious. So using that very brief primer on the approach to anesthetic planning, let’s look specifically at several case examples that comprise the everyday challenges we see in our practice: Case One: 12 Year Old Spayed Female Poodle Presenting Complaint: Halitosis, Reluctance to eat, “Painful mouth” Initial physical exam reveals – Quiet, alert dog – Lean body condition – Heart rate 120, Respiratory rate – panting – Heart murmur heard on auscultation Grade V/VI • Left apical systolic murmur – Lung sounds difficult to evaluate initially (panting) – Significant dental tartar, gingivitis, missing incisors Pertinent History – Exercise tolerance: Activity level has decreased with age. – Coughing: Occasional coughing at night – Current medications: furosemide, enalapril and pimobendan Clinical and Diagnostic Plan Mitzi needs dental cleaning and tooth extractions Main concerns are geriatric status and assessment of cardiac disease Evaluate Mitzi’s status to determine her ability to safely undergo general anesthesia for dentistry • Thorough complete physical exam • Special emphasis on signs commonly associated with heart disease – Pallor, cyanosis, slow capillary refill? – Weak peripheral pulses? – Jugular venous pulses? – Edema, ascites, depression? – Cough, increased work of breathing? • Special Attention to Auscultation Murmurs or abnormal heart sound Irregular rhythms? Pulse deficits? Abnormal lung sounds? Crackles? www.cvmbs.colostate.edu/clinsci/callan/breath_sounds. htm • Minimum Data Base? Complete Blood Count Serum Biochemistry Thoracic Radiography Additional Data in Certain Cases Electrocardiography Urinalysis Blood pressure measurement SpO2 Arterial blood gas analysis Heartworm test Serum thyroid hormone level There may be expanded databaserequired when the plan is to anesthetize a patient with cardiovascular disease. This database is not always necessary however on occasion there will be other diagnostics that are indicated in particular patients. The database that is required tends to expand with the severity of the cardiac disease, or with the difficulty of making a diagnosis of the condition. In an emergency situation it may not be easy even to obtain the customary minimum of data. From the CBC, hematocrit can indicate hydration status, presence of anemia, oxygen-carrying capacity, and blood viscosity. Total protein indicates hydration status, and any increased risk for development of pulmonary edema. Abnormal serum electrolytes may indicate a predisposition to cardiac arrhythmias, or explain the presence of pre-existing rhythm disturbances. Serum urea nitrogen allows one to evaluate renal function and along with urinalysis it can indicate the possibility of pre-renal vs. primary renal azotemia. Hepatic enzymes can indicate the presence of liver damage or suggest impaired liver function, which may suggest altered anesthetic drug clearance. Thoracic radiographs help to evaluate cardiac size and contour. Other thoracic structures can be identified, pulmonary edema may be evident and the animal’s response to therapy can be evaluated before anesthesia. Electrocardiography is absolutely essential to diagnose rhythm disturbances that may have been evident on auscultation or in palpating peripheral pulses. An ECG is necessary to evaluate response to therapy (e.g. antiarrhythmics or correction of electrolyte abnormalities) Heartworm disease assessment is important in regions endemic for the disease, based on a history of no preventative therapy or suspected poor client compliance in administration of preventative. Assessing a patient’s oxygenation (SpO2) with Pulse Oximetry can be worthwhile if there is some question about pulmonary overcirculation or evidence of increased respiratory rate or effort. Arterial blood gas analysis can indicate the degree of ventilatory compromise especially in the presence of pulmonary edema. It allows one to assess oxygen-carrying capacity. ABG’s also indicate metabolic status and the need for fluid or electrolyte adjustments prior to anesthesia. Cardiac disease associated with low cardiac output often results in metabolic acidosis due to diminished tissue perfusion. Thyroid hormone levels can indicate the presence of hyperthyroidism (feline patients), which is the cause of thyrotoxic cardiac disease. In addition, hypothyroidism can alter an animal’s level of sensitivity to anesthetic agents and when detected often suggests adjustment in dose regimen. Blood pressure measurement has become increasingly important as a preanesthetic evaluation tool. In recent years hypertension has been increasingly diagnosed in our small animal patients. This may occur as a result of chronic renal disease, it may be a manifestation of cardiovascular disease, idiopathic hypertension also occurs. My preferred method of assessment is the Doppler ultrasound device with a repeated value greater than 160 mmHg obtained in calm setting being evidence of hypertension in a patient. • Echocardiography The essential tool of the cardiologist Allows diagnosis of specific cardiac or vascular anatomic disorders Allows evaluation of chamber enlargement and chamber volume Allows assessment of heart function Doppler echo allows identification of regurgitant flow and quantification of pressure gradients across valves One of the most useful parameters from cardiac echocardiography, from an anesthesia point of view is measurement of cardiac function. Although specific measures can be taken to control preload, afterload, heart rate in many cardiac disorders, a significant compromise in cardiac contractility is difficult to overcome during anesthesia even with the use of inotropic agents. Systolic Time Intervals can be determined with M-mode echocardiography and simultaneous ECG. It is calculated by determining the pre-ejection period (PEP) and the left ventricular ejection time (LVET). The PEP is the time from the Q wave on the ECG (beginning of ventricular depolarization) to the opening of the aortic valve (onset of LV ejection). The LVET is measured from the opening of the aortic valve to the closing of the aortic valve. The PEP/LVET = Systolic Time Interval (STI). This parameter is affected by heart rate and preload. The normal values for the dog are 0.24 – 0.34 msec and for the cat are 0.38 – 0.40 msec. Better contractility occurs when the PEP is shorter and the LVET is longer. An increase in STI therefore indicates less contractility. It is however nonspecific measure of contractility since it is affected by loading conditions. It does give a reasonable indication of global left ventricular performance. Ejection phase indices are given most frequently for contractile function in the heart. These parameters are also affected by loading conditions just like STI. Left ventricular fractional shortening (%FS) is calculated as the change in LV dimension from end diastole to end systole. It is calculated as [LVEDD – LVESD / LVEDD] x100. As a rule %FS should be > 30 in dogs, slightly less in large breed dogs and 40-50 in cats. Ejection fraction may be a superior measurement of cardiac function to the other ejection phase indices because it is threedimensional rather than one-dimensional. It therefore is not so dependent on proper perpendicular and centerline orientation of the ultrasound beam through the LV. Ejection fraction is the measure of the percentage of end diastolic volume that is ejected when the heart beats. It is calculated as [EDV-ESV / EDV] x 100. Values greater than 40% are considered adequate, however there is no standardization at this time for this particular measure in dogs and cats. • • • • 1. 2. 3. 4. • • • • • • • • • • • • Mitzi’s Laboratory Data Results Mitzi’s Thoracic Radiographs Mitzi’s Echocardiographic Exam Data What is the most likely diagnosis of Mitzi’s cardiac disease? Dilated cardiomyopathy Chronic valvular disease with mitral insufficiency Subaortic stenosis Bacterial endocarditis Chronic Degenerative Mitral Valve Disease What is the pathophysiology of this disease? How does the animal adapt to this condition? What is the risk of anesthesia? Mitral Valve Insuffiency Chronic volume overload Results in ventricular dilation Stroke volume is divided into forward and regurgitant flow No period of isovolumetric contraction in LV Expected patterns of response as seen with echocardiography Volume Overload – Eccentric hypertrophy – Dilation of ventricle in systole – Normal wall thickness – Systolic function is usually OK – LV wall motion during systole may appear hyperdynamic (normal to increased %Fractional Shortening) Mitral Valve Insufficiency • Animals are asymptomatic for a long period because afterload is low, oxygen demand is low, LVEDP does not ↑ • Volume of regurgitant flow is a function of size of mitral valve orifice, time of flow and pressure gradient across mitral valve • Regurgitant orifice size is a function of LV size • Goal of anesthesia is to promote forward flow, reduce regurgitation • Dynamic factors that can increase regurgitant volume – Increases in preload • Avoid bradycardia • Avoid IV fluid overload – Increases in afterload • Avoid vasoconstriction – Decreases in contractility • Avoid decreases in sympathetic tone • Mitzi Anesthetic Protocol? • How do we anesthetize this dog to achieve the above goals while at the same time providing stable period of general anesthesia with adequate analgesia for dentistry with tooth extractions • Supportive Measures • What would be the best approach to treatment of hypotension if/when it occurs in this particular patient? • • Treatment of hypotension also is best when we know the likely cause, but we are directed in our best approach in this particular patient going back to the dynamic factors that will worsen regurgitant conditions. We want to avoid increases in afterload and IV fluid overload, which leaves increases in HR and contractility (inotropic agents) as our best options for treatment of hypotension. Case Two: 8 YearOld Spayed Female Cocker Spaniel Presenting complaint blindness and painful eye • Diagnosis Chronic Glaucoma with poor response to medical treatment • Requires general anesthesia for planned enucleation of the affected eye • Initial physical exam reveals – Bright, active, nervous dog – Body condition score 4/5 – Heart rate 120, Respiratory rate 30 – Evidence of chronic atopic dermatitis – Diagnosed and treated for past two years as a diabetic on insulin therapy • Minimum Data Base • Complete Blood Count • Serum Biochemistry • Urinalysis or Urine Dipstick • Goldie’s Current Values – CBC within normal limits – Serum Chemistry abnormal values included • Glucose 332 mg/dl • Alkaline phosphatase 284 U/L • Serum bicarbonate 19.9 mmol/L – Urine dipstick is positive for trace glucose • Anesthetic Best Practices for Diabetics – Schedule the surgery for the morning – The remainder of the day to monitor • • • • • • • • – Shortens fasting time from the night before – Withhold food the morning of surgery – Measure a blood glucose – Based on result calibrate AM dose of insulin – How much insulin to give? – Zero up to full dose! Does it matter? Anesthesia and the Diabetic No data in animals regarding the risk of poor glucose control in diabetic animals prior to anesthesia Studies in both diabetic and nondiabetic people suggest adverse events are associated with hyperglycemia – Surgical site infection – Myocardial infarction – Stroke – Increased mortality In people, fluctuations of blood glucose and hypoglycemia correlate with impaired prognosis Insulin Perioperative Therapy Comparison of two insulin protocols for diabetic dogs undergoing cataract surgery. Kronen PWM, Moon-Massat PF, Ludders JW et al. Vet Anaes Analg 2001 – Compared administration of 25% or 100% of the normal insulin dose subcutaneously the morning of surgery – Administration of full does only marginally advantageous for reducing glucose to normal (70 – 120 mg/dl) – Neither dose consistently induced glycemic values in an acceptable range (70-200 mg/dl) – No hypoglycemic episodes with 25%, but did occur in 100% dose, although infrequent Anesthetic Complications of Diabetics? A comparison of anesthetic complications between diabetic and nondiabetic dogs undergoing phacoemulsification cataract surgery: a retrospective study. Oliver JAC, Clark L, Corletto F, and Gould DJ: Veterinary Ophth 2010 • • • • • • • • • • – 66 diabetic and 64 nondiabetic dogs – Same anesthetic technique in each group – Diabetic dogs were more likely to develop moderate and severe intraoperative hypotension than non diabetic dogs – 71% vs. 63% Why more hypotension? Investigators proposed hypotension due to hypovolemia secondary to hyperglycemia and osmotic diuresis Cardiovascular Autonomic Diabetic Neuropathy? – Documented in humans with diabetes – Peripheral autonomic nerve fibers of the CV system are affected – Associated with hypotension perioperatively – 25% of patients with type 1 diabetes – Limited evidence for this in dogs, although other peripheral neuropathies have been identified Diabetic Monitoring and Therapy Draw a Blood glucose prior to premedication Repeat measurement every 30-60 minutes during anesthesia – Blood glucose 100 - 200 mg/dl (5.5 - 11 mmol/l) • Lactated Ringer’s solution – Blood glucose < 100 mg/dl (5.5 mmol/l) • 2.5% dextrose in LRS • 2-5 ml/kg/hour rate of administration Target for Blood Glucose 90 – 180 mg/dl What about hyperglycemia? Do nothing, wait for AM insulin to peak – When do you expect peak effect? Can it wait? • • Administer short (regular) or ultra-short acting insulin as a bolus or CRI • Regular insulin CRI rate ≤ 0.1 units/kg/hour – Dogs: 2.2 units/kg of regular insulin added to 250 ml 0.9% NaCl • Serum glucose > 250 mg/dl administer at 10 ml/hr • Serum glucose = 200 - 250 administer at 7 mls/hr • Continue to frequently monitor glucose levels to achieve target level and adjust CRI rate as needed • Specific Drug Choices for Diabetics? Technique appropriate for the age and physiologic status of the patient Continue to monitor blood glucose Return to normal routine as soon as possible but do not feed if heavily sedated Case Three: 3Year Old, Intact FemaleShih-Tzu • Chief complaint:Unproductive labor X 18 hrs – Panting, shivering, not eating – History:1 previous pregnancy – 63d post breeding – No current medications • • • • • • • • • • • • • – Plan is to provide general anesthesia for emergency cesarean section due to prolonged labor with inadequate progress Overview of Normal Gestation/Parturition Normal gestation period – 63 days (dogs), 63-65 days (cats) Assisted delivery or cesarean is unnecessary for most small animal parturitions Retrospective study, 151 breeds reviewed, 13,141 bitches, 22,005 litters >80% Boston terrier, Bulldog, French bulldogs Evans KM, Adams VJ: Proportion of litters of purebred dogs born by caesarean section. J Small Anim Pract 2010; 51, 113–118. Cesarean Section Anesthesia: Management goals Provide maternal analgesia & muscle relaxation Prevent maternal/fetal hypoxia & hypoperfusion – Minimize changes in uterine blood flow Minimize fetal CNS depression Minimize post anesthetic maternal depression It is important to understand the physiologic alterations brought on by pregnancy Cardiovascular – Maternal blood volume & body water ↑ – PCV & Hemoglobin ↓ – HR, SV, & CO ↑ – SVR ↓, BP is unchanged – CVP ↑ – Cardiac reserves ↓ Respiratory – Sensitivity to PaC02 ↑ (progesterone) – Minute volume ↑ with resulting ↓ PaC02 – No long term acid-base changes – Oxygen consumption ↑ • Respiratory – Lung compliance is unaffected – Pa02 unchanged – FRC ↓ • Gastrointestinal – Lower esophageal sphincter tone ↓ • Gastric pH ↓ – Gastric emptying/motility ↓ – Intragastric pressure ↑ • Metabolism & Renal/Hepatic – Normal biotransformation of drugs – Inhalant anesthetics – More effective alveolar ventilation for faster uptake and elimination – MAC of inhalants is decreased • Progesterone & endorphins? • Isoflurane MAC decreased by up to 40% – Renal blood flow & GFR ↑ – BUN & Creatinine ↓ • Uterine blood flow • UBF = Systemic perfusion pressure/myometrial vascular resistance • Placental hypotension: – Maternal hypovolemia – Anesthetic induced cardiac depression – Sympathetic drugs increasing vascular resistance (alpha 1 effect) – Results in placental hypoperfusion, fetal hypoxia, acidosis, & fetal distress • Placental drug transfer • Placenta is highly permeable to anesthetic drugs • Induce proportionate fetal effects • Occur by simple diffusion • Influenced by: • • • • • • – Molecular weight – Protein binding – Lipid solubility – Degree of ionization Drug selection Premedication – Often not needed/indicated – Avoid drugs with long and/or profound effects • Avoid acepromazine, alpha 2 agonists, and benzodiazepines in general – If very anxious select a short duration drug: • Fentanyl 2.5-5mcg/kg IV, IM, SQ • Butorphanol 0.1-0.2mg/kg IV, IM, SQ Premedication – Opioids often withheld until puppies or kittens are removed from dam – Anticholinergics typically not indicated • Glycopyrrolate does not cross the placenta • 0.005-0.02mg/kg IM, SQ, IV • Drug selection Anesthesia induction • Propofol/Propofol 28: 4-8mg/kg IV • Alfaxalone: 1-4mg/kg IV • Not currently available in US • Etomidate: 1-2mg/kg IV • Reserved for very unstable cases • Avoid Ketamine/Benzodiazepine & Thiopental • Associated with more negative outcomes regarding fetal viability Drug selection Anesthetic maintenance • Inhalant • Sevoflurane > Isoflurane? • Lower blood: gas solubility (0.7 vs. 1.4) • • • • • – Faster onset, more rapid depth changes & recovery • Total intravenous anesthesia (TIVA) • Propofol CRI 0.2-0.5mg/kg/min • Alfaxalone CRI Drug selection Epidural drug administration • Pros: • Minimal depression of fetus & newborn • Reduces inhalant requirement (local anesthetic, such as lidocaine) • Long duration of analgesia (opioid) – Morphine 12-24 hours • Cons: • Slow onset (opioid) • Hypotension risk (local anesthetic) • May add time before getting into OR Epidural drug administration • 3mg/kg lidocaine + 0.1mg/kg morphine – Use preservative free drugs • 4-6mg/kg lidocaine • Line block with lidocaine along the Incision site? • Lidocaine or bupivacaine? Post-operative analgesia • Opioids administered to mother once fetuses removed • Full mu agonist preferred – Hydromorphone, Morphine, Methadone, Oxymorphone, – Can reverse opioids given to the dam in a depressed offspring with sublingual naloxone • Buprenorphine Post-operative analgesia • Single dose NSAID • Meloxicam, Robenacoxib, Carprofen • • • • • • • • • • • • • • • • Acetaminophen • Contraindicated in cats • Tramadol • Mathews KA: Analgesia for the pregnant, lactating and neonatal to pediatric cat and dog. J Vet Emerg Crit Care 2005; 15(4) 273-284. Perioperative care Degree of care necessary depends on presenting condition of the dam. IV catheter & fluid administration Evaluate Ca2+, Glucose, & electrolytes pre-anesthesia Pre-oxygenate • Avoid hypoxemia Ensure OR set up & surgeon or surgery is ready to go before induction Pre-clip belly & initial prep abdomen Perioperative care • High regurgitation risk • Rapid induction, head up, cuffed ET tube, secure airway quickly Remember MAC ↓ in pregnancy Ventilate as needed (ETCO2 = 40mmHg) • Avoid hypoventilation • Uterine blood flow ↓ Avoid excessive time spent in dorsal recumbency • Gravid uterus may decrease venous return Newborn Resuscitation Provide oxygen supplementation Vigorously dry newborns & keep warm • Huck towels, Bair-hugger, incubator, etc. Stimulate newborns • Reflex: Genital & umbilical → respiratory stimulation GV26 (Jen Chung) – acupuncture point at base of nasal philtrum → respiratory stimulation Drug support • Epinephrine 1:1000- 1 drop sublingual • Naloxone- 1 drop sublingual if opioids have been given to dam • Atropine • No effect on HR before 11-14d (Grundy 2006) • Doxapram • Not recommended in humans or animals • ↑ cerebral oxygen demand and ↓ CBF & oxygen delivery (Dani et al. 2006) Disinfect and ligate umbilicus Inspect newborns for congenital abnormalities Return to dam once she is awake and cognizant postanesthesia Have patience! Many neonates will revive slowly upon delivery but will become quite vigorous after 10-15 minutes of careful stimulation and support Clinical Case PE: • QAR, T: 99.9F, P: 180bpm, R: panting • 5% dehydrated • Otherwise unremarkable Diagnostics: • CBC/Chemistry • Stress leukogram, HCT = 37%, BG= 154mg/dl, • TP = 5.2g/dl, Ca = 9.2mg/dl, HC03 = 17U/L • Abdominal US • 4 puppies identified • 3 puppies in distress (HRs 80-130bpm) Clinical Case Management 10ml/kg IV LRS bolus prior to beginning of procedure • Prior to induction • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • Pre-oxygenation Clip & prepped belly Anesthetic plan No premedication Propofol IV to effect (6.4 mg/kg) Rapidly secured airway Sevoflurane in 100% oxygen Placed into lateral recumbency Administered epidural at lumbosacral site Lidocaine 3 mg/kg Preservative-free morphine 0.1 mg/kg Placed into dorsal recumbency HR= 150bpm, RR=35bpm, ETCO2 = 40mmHg, BP = 85mmHg (Doppler Systolic BP), Sp02 = 100% Hypotension noted ↓ Sevoflurane 4% → 2.75% 10ml/kg LRS IV bolus 0.1mg/kg IV ephedrine HR=120bpm, RR = 25bpm, ETC02 = 37mmHg, BP = 105mmHg (Doppler Systolic BP), Sp02 = 99% Case Four: 9 Year Old, Neutered Male Miniature Schnauzer • Owners complaint: Stranguria, hematuria, pollakiuria • Diagnosis Cystic calculi • Plan is for general anesthesia to remove cystic calculi via cystotomy • Physical Exam • Current Medications – Clavamox to treat UTI – Fluoxetine (2 mg/kg SID) for separation anxiety • Minimum Data Base – CBC – Serum chemistry • • • • • • • • • • • • – Urinalysis Anesthesia for Abdominal Exploratory Routine anesthetic approach – Analgesic concerns for abdominal procedure with bladder incision as well What role does continued administration of fluoxetine play in anesthetic drug choice or management in this dog? Fluoxetine (Prozac/Reconcile) is a selective serotonin reuptake inhibitor (SSRI) – Major actions to block 5-HT re-uptake into pre-synaptic nerve endings allowing it to persist longer in serotoninergic synapses – Also has 5-HT2C antagonist action which plays an antianxiety role – Sigma-1 receptor agonist which is produces an antidepressant effect in people SSRI’s Side Effects SSRI’s are metabolized by cytochrome P450 enzyme system (isoenzyme 2D6) – Other drugs using this same pathway can undergo impaired or slower metabolism – Other tricyclic antidepressants, lipophilic beta-blockers, codeine SSRI’s have been associated with rhythm disturbances in people with chronic use – Tachyarrhythmia’s, syncope from hypotension – Typical ECG alterations: flattened T waves, prolonged QT interval, ST segment depression Serotonin Syndrome Excessive serotonin agonism Potentially life-threatening adverse drug reaction Overstimulation of 5-HT1A receptors Triad of symptoms – Neuromuscular hyperactivity Autonomic hyperactivity Altered mental status SSRI’s, tricyclic antidepressants and MAO inhibitors are all associated with this syndrome Syndrome can occur with these drugs in combo or at higher doses individually The addition of a drug that can inhibit the cytochrome P450 system for these drugs increases chance of syndrome Drug interactions with SSRI’s Avoidance of anesthetic agents that potentiate 5-HT will avoid this likelihood Phenylpiperidine opioids are weak 5-HT re-uptake inhibitors – Fentanyl, Tramadol, Methadone, Dextromethorphan, Propoxyphene Safe Opioid choices to use with SSRI’s – Morphine, hydromorphone, oxymorphone Ondansetron as a 5HT-3 receptor antagonist increases 5HT availability at 5-HT1 and 5-HT2 receptors – For anti-emetic effect: choose maropitant or metoclopramide Benzodiazepines, especially midazolam are metabolized by CYP enzymes and may increase half-life and plasma levels of SSRI’s Lipophilic beta blockers may be associated with serious bradycardia in SSRI treated patients – Water-soluble beta blockers such as atenolol are the recommended choice if needed – Summary Most anesthetic agents directly or indirectly effect the a number of body systems The stress of anesthesia is well-tolerated in normal patients – – • • • • • • • • • • • • • • The presence disease requires careful drug choices, modification of dose, titration to effect, and a balanced multidrug approach • Make anesthetic choices based on best understanding of physiologic consequences of disease and the progression of the disease process in the patient is the best approach • Often it is not about the drug choices at all, but about the perioperative patient management that makes all the difference in success of the anesthetic episode